- Vascular Biology Research Group, Institute of Molecular and Clinical Sciences, St George’s University of London, London, United Kingdom
The KCNQ family is comprised of five genes and the expression products form voltage-gated potassium channels (Kv7.1–7.5) that have a major impact upon cellular physiology in many cell types. Each functional Kv7 channel forms as a tetramer that often associates with proteins encoded by the KCNE gene family (KCNE1-5) and is critically reliant upon binding of phosphatidylinositol bisphosphate (PIP2) and calmodulin. Other modulators like A-kinase anchoring proteins, ubiquitin ligases and Ca-calmodulin kinase II alter Kv7 channel function and trafficking in an isoform specific manner. It has now been identified that for Kv7.4, G protein βγ subunits (Gβγ) can be added to the list of key regulators and is paramount for channel activity. This article provides an overview of this nascent field of research, highlighting themes and directions for future study.
Introduction
There are 5 Gβ and 11 Gγ proteins that associate to form a tightly bound dimer, which function as a single entity (Schmidt et al., 1992; Khan et al., 2016). Gβγ subunits associate with Gα subunits (Gαs, Gαi/o, Gαq/11) to form the heterotrimeric G proteins, crucial intermediates for a myriad of cell surface G-protein coupled receptors (GPCRs). However, the 7β propeller structure of Gβ proteins enables interaction with multiple effectors including adenylate cyclases, tyrosine kinases, phospholipases, G-Receptor kinases and MAP kinases (Lin and Smrcka, 2011). In cardiac cells and neurones stimulation of GPCRs coupled to Gαi/o evokes a K+ conductance due to the translocation and binding of Gβγ to Kir3.1/3.4 potassium channels, subsequently termed GIRKs (G protein activated Inwardly Rectifying K+ channels) (Logothetis et al., 1987; Dascal and Kahanovitch, 2015). Protein biochemistry studies revealed that Gβγ subunits modulate Kir3.1 and Kir3.4 (GIRK1 and GIRK4, respectively) through an interaction with residues 253–348 in the C-terminal as well as residues 41–92 in the N terminus (Huang et al., 1995; He et al., 1999; 2002; Ivanina et al., 2003; Kahanovtch et al., 2014; Touhara and MacKinnon, 2018; Tabak et al., 2019). The molecular determinants of Gβγ binding to GIRKs has been identified by X-ray crystallography (Whorton and MacKinnon, 2013) and is affected by interaction with phosphatidyl inositol bisphosphate (PIP2), phosphorylation, scaffold proteins and even Gαi/o proteins (Dascal and Kahanovitch, 2015). Gβγ-dependent activation of GIRKs is a powerful physiological mechanism yet, except for inhibition of CaV2 channels (Herlitze et al., 1996; Ikeda, 1996; Proft and Weiss, 2015) and the recently discovered modulation of TRPM3 channels, examples of Gβγ modulating other ion channels are rare. This article highlights a nascent research field about Gβγ regulation of Kv7 channel voltage-gated potassium channels.
Kv7 channels
The Kv7 channel subfamily is comprised of five members, Kv7.1–Kv7.5, encoded by the genes KCNQ1 to KCNQ5, which have been identified as key players in controlling excitability and physiological function in many cell types (Barrese et al., 2018). Kv7 proteins have the standard protein topography consistent within the Kv channel family with 6 main transmembrane domains, a pore and selectivity filter created by amino acids between the 5th and 6th domains and a voltage-sensing unit comprised of transmembrane domains one to four with a positively charged 4th domain providing voltage sensing (Coetzee et al., 1999; Ranjan et al., 2019). All Kv7 channels are tetramers with Kv7.1 conventionally forming homotetramers whilst the other Kv7 proteins are capable of heterotetramerisation determined by coiled-coil motifs in the distal C-terminus (Schwake et al., 2003; 2006).
In terms of expression, in the human body Kv7.1 is found in the cochlea and epithelia as well as cardiac myocytes, where it mediates late repolarisation of the action potential. Kv7.2/7.3 channels are robustly expressed in central, peripheral, and sensory neurons, where they underlie a K+ conductance known as the M-current crucial for limiting neuronal excitability (Jentsch, 2000; Soldovieri et al., 2011). Kv7.4 is found in the cochlea as well as smooth muscle where it opposes muscle contraction (Greenwood and Ohya, 2009; Haick and Byron, 2016). Kv7.5 is also located in smooth muscle usually in association with Kv7.4 (Brueggemann et al., 2014; Chadha et al., 2014), as well as neurones and skeletal muscle (Barrese et al., 2018). Effective functioning of Kv7 channels is essential for homeostatic processes and when Kv7.1-7.5 channels do not work the consequences can be disastrous. Relatively rare inherited disorders like Long QT syndrome-associated arrhythmia or epileptic encephalopathy as well as more common congenital diseases like atrial fibrillation and non-syndromic deafness are associated with mutations to KCNQ genes (for more details see Barrese et al., 2018; Nappi et al., 2020; Vigil et al., 2020; Huang et al., 2023). Moreover, corruption of Kv7 function has been linked to development of multiple disorders which pose a significant health burden. This includes hypertension, neuropathic pain, urinary incontinence and pre-term labour (see Jepps et al., 2011; 2016; McCallum et al., 2011; Svalø et al., 2015; Carr et al., 2016).
Kv7 regulation
Kv7 channels are opened by membrane depolarisation due to coupling of the voltage-sensing domain with the pore loop (see Wang et al., 2020 for overview). In addition, Kv7 channel activity is regulated by several modulators (see Haitin and Attali, 2008; Barrese et al., 2018) with PIP2 and calmodulin having considerable control over channel activity.
Structure-function studies have identified PIP2 and calmodulin binding sites in the distal C-terminus (Haitin and Attali, 2008; Hernandez et al., 2008). Additional PIP2 binding sites have been identified at amino acids in S2-S3 and S4-S5 linkers depending upon the Kv7 isoform (Choveau et al., 2018; Brueggemann et al., 2020). The activity of all Kv7 channels is enhanced by PIP2 (Li et al., 2005; Hernandez et al., 2008, see Zaydman and Cui, 2014 for a fuller summary), which alters the open probability of Kv7 channels through various mechanisms (see Zaydman and Cui, 2014). Stabilization of the voltage-sensing domain-pore gate coupling is a proposed model for the action of PIP2 on Kv7.1 (Sun and MacKinnon, 2020). Calmodulin binds to a site overlapping with the PIP2 binding domain on the C-terminus (Haitin and Attali, 2008) and leads to inhibition of Kv7.2/7.3, Kv7.4 and Kv7.5 but stabilises Kv7.1 activity (Gamper et al., 2005; Tobelaim et al., 2017).
The biophysical, pharmacological and trafficking properties of Kv7 channels are also dictated by association with proteins encoded by the KCNE gene family (KCNE1-5, Abbott, 2020; 2022). The best studied of Kv7-KCNE interactions is Kv7.1 and KCNE1, which constitute channel responsible for the slowly activating late component of ventricular and atrial action potential repolarisation (Barhanin et al., 1996). In this case the KCNE1 protein interacts with the voltage-sensor domain and slows channel opening (Nakajo and Kubo, 2007; Abbott, 2022). However, Kv7.1 also associates with KCNE2 and KCNE3 in epithelial cells and here the channel loses time-dependent properties as the voltage-sensor becomes locked by the interleaving of the KCNE proteins (Abbott, 2022). In smooth muscle cells Kv7.4 and Kv7.4/7.5 heteromers associate with KCNE4 (Jepps et al., 2015), which increases membrane abundance and voltage-sensitivity. Different Kv7 channels are also modulated by protein kinase A and protein kinase C that associate with the channel through interactions with A-kinase anchoring proteins (AKAPs) (Haitin and Attali, 2008; Barrese et al., 2018). Consequently, Kv7 channels exist in a multi-protein complex with many interacting modulators.
Kv7 channels and Gβγ
In 2015 Stott et al. identified that Gβγ regulates Kv7.4, the Kv7 isoform that is abundant in arterial smooth muscle (Stott et al., 2015b). Intracellular perfusion of active Gβγ isolated from bovine brain augmented the amplitude of potassium currents evoked by membrane depolarization in Human Embryonic Kidney cells (HEKs) constitutively expressing Kv7.4 (see Figure 1 for example). The augmentation took about 5 min to plateau and was associated with an approximate halving of the slow time constant of activation and −5 mV shift in the voltage dependence of activation. Experiments performed with excised patches of cell membrane with the internal surface facing the bathing solution (termed inside out patches) revealed that Gβγ produced a concentration-dependent (0.4–50 ng/mL) increase in open probability with an approximate concentration for half maximal stimulation of 8 ng/mL (Povstyan et al., 2017) without altering the unitary conductance (Stott et al., 2015b; Povstyan et al., 2017), that was identified as 2.3 pS consistent with other studies (Li et al., 2005). Heterologously expressed Kv7.4 channel currents were also augmented with a concomitant reduction in activation kinetics by stimulation of P2Y receptors endogenous to HEK cells with ATP (Stott et al., 2015b).
Figure 1. Illustration of the effect of Gβγ on Kv7.4 channels. (A,B) show potassium currents generated at different test potentials from −80 mV to + 40 mV in CHO cells expressing Kv7.4 in the absence (A) or presence (B) of internal perfusion with Gβγ. (C) is a cartoon representation of the importance of Gβγ on Kv7.4 channels both at rest (left panel) and in response to receptor-agonists (right). Kv7.4 association with Gβγ is crucial for channel function in many arteries. Gβγ -effector inhibitors suppress heterologously expressed voltage-gated potassium currents in the absence of any receptor stimulation or artificial enrichment. Gβγ association with Kv7.4 is also critical for PKA to enhance channel activity and produce relaxation in some arteries (e.g., renal). However, in other arteries cAMP signalling via EPAC is not reliant upon Gβγ.
In a more physiological scenario, native Kv7 currents in freshly dispersed renal artery smooth muscle cells were enhanced by intracellular perfusion with brain derived Gβγ (Stott et al., 2015b). There are five isoforms of Gβ that have differential effects on target proteins (Schmidt et al., 1992; Khan et al., 2016). Co-expression of plasmids containing Gβ1 or Gβ3 in Kv7.4 expressing Chinese Hamster Ovary cells produced an increase in current amplitude, leftward shift in voltage-dependence and reduction in the kinetics of activation that were analogous to the effects of purified brain Gβγ (Greenwood and Stott, 2020). Similar effects were observed with Gβ5, which is structurally dissimilar to the other 4 Gβ isoforms (Khan et al., 2013), but not with overexpressed Gβ2 or Gβ4 (Greenwood and Stott, 2020). Interestingly, molecular knockdown of Gβ3 but not Gβ1 or Gβ5 reduced native Kv7 channel currents in renal artery smooth muscle cells (Greenwood and Stott, 2020). There are 12 genes that encode for Gγ subunits, and the expression products are structurally more diverse than Gβ (27%–76% similarity, Dupré et al., 2009). There is no information about individual Gγ subunits differentially affecting ion channels.
Constitutive activity-an obligatory role for Gβγ
GIRK channels are modulated by Gβγ subunits at rest (basal activity) and augmented by Gβγ liberated upon activation of receptors coupled to (Kahanovtch et al., 2014). Kv7.4 channels appear to operate in a similar manner but with the basal interaction being more important than with GIRKs. Proximity ligation assays (PLA, Soderberg et al., 2008) with antibodies against Kv7.4 and pan-Gβ revealed considerable association between the two proteins in heterologous expression systems and arterial smooth muscle cells in the absence of receptor stimulation or internal enrichment with Gβγ (Stott et al., 2015b). PLA with antibodies specific for Gβ1 or Gβ3 also exhibited significant basal interaction with Kv7.4 in renal artery myocytes whereas Gβ2 and Gβ4 did not interact. Moreover, structurally different prohibitors of Gβγ-protein interaction not only prevented Kv7.4 current enhancement by Gβγ enrichment but also abrogated Kv7.4 currents. Thus, voltage-dependent K+ currents in HEKs constitutively expressing Kv7.4 were reduced to negligible levels after 10min application of the small molecule inhibitors gallein, M199K and M201; a peptide mimetic of the G-protein receptor kinase (Grk2i) and an antibody against Gβ (Stott et al., 2015b; Povstyan et al., 2017). Gallein, M201 and Grk2i also reduced the open probability of Kv7.4 channels recorded in inside-out patches or cell attached recordings to negligible levels (Stott et al., 2015b; Povstyan et al., 2017) and reduced the number of protein-protein interactions derived by proximity ligation assay. These data revealed that the association of Gβγ with the Kv7.4 channel was obligatory for the channel to respond to membrane depolarisation.
Kv7.4-Gβγ relationship in receptor mediated vasorelaxations
The powerful regulation of Kv7.4 by Gβγ has considerable physiological relevance in arterial smooth muscle both at rest and in the vascular response to receptor-linked vasodilators. In arterial smooth muscle cells Kv7.4 exists predominantly as a heteromer with Kv7.5 (Chadha et al., 2014; Brueggemann et al., 2014). Application of pan-Kv7 blockers like linopirdine or XE991 either produce a contraction, which is sensitive to calcium channel blockers, or sensitizes vasoconstrictor responses. Agents that activate Kv7 channels like ML213, retigabine, maxipost are effective relaxants of precontracted arteries (e.g., Jepps et al., 2015). PLA has revealed a high level of association between Kv7.4 and Gβγ in rat renal arterial smooth muscle cells (Stott et al., 2015b) in the absence of any stimulant. Application of gallein or M199K reduced the number of PLA punctae considerably and caused a marked contraction of the renal artery (Stott et al., 2018), which was equivalent to the effect of a direct Kv7 channel blocker such as linopirdine (Stott et al., 2018). These data suggest that in renal arteries Kv7 channels are important determinants of resting arterial tone that is reliant upon an interaction with Gβγ. In mesenteric arteries there are fewer interactions of Kv7.4 with Gβγ and neither gallein nor Kv7 channel blockers contract the artery. These observations provide credence that Kv7.4-containing channels regulate resting arterial smooth muscle contraction that is reliant upon association with Gβγ but highlight the underlying interaction is complex (Figure 1).
The Kv7.4-Gβγ relationship is also important in receptor-mediated vasorelaxations. In arterial smooth muscle various agonists of Gs-coupled receptors like isoprenaline (mixed β-adrenoceptor) adenosine and calcitonin-gene related peptide, and cGMP stimulants such as atrial natriuretic peptide produce vasodilatation that is impaired if Kv7 channel blockers are present (Chadha et al., 2012; Khanamiri et al., 2013; Stott et al., 2015a; Morales-Cano et al., 2015; Stott et al., 2016; Stott et al., 2018; Mondéjar-Parreño et al., 2019; Baldwin et al., 2022). Similarly, impairment was observed if Kv7.4 or Kv7.5 was reduced by morpholino or siRNA-mediated molecular interference (Chadha et al., 2014; Stott et al., 2018). Interestingly, the nature of the coupling between Gs-linked receptor and Kv7 channels is artery specific. In renal arteries, the β-adrenoceptor-mediated responses are driven via protein kinases A and an associated A-kinase anchoring protein whereas in mesenteric artery isoprenaline-derived relaxations are mediated by EPAC (Exchange Protein Activated by Cyclic AMP) signalling via the downstream mediators Rap1A and Rap2 with Kv7.4 in these vessels. Thus, PKA or AKAP inhibitors attenuated linopirdine-sensitive isoprenaline relaxations of renal artery, but EPAC inhibitors reduced isoprenaline-mediated relaxations of mesenteric artery (Stott et al., 2016).
With respect to Gβγ role in Kv7.4 activity, cell attached recordings from renal artery smooth muscle cells showed that the activity of linopirdine-sensitive K channels was enhanced by isoprenaline in a gallein-sensitive manner (Stott et al., 2015b). Moreover, isoprenaline increased the number of PLA punctae derived from Kv7.4-Gβγ antibodies (Stott et al., 2018). In addition, gallein impaired the isoprenaline-mediated relaxations in renal artery (Stott et al., 2018). Gallein and M199K also prevented calcitonin-gene related peptide-induced relaxations in mesenteric and cerebral arteries (Meens et al., 2012; Stott et al., 2018). Interestingly, whilst isoprenaline-mediated relaxations of mesenteric artery are sensitive to Kv7 blockade they are not sensitive to Gβγ blockers. Thus, while PKA dependent relaxation of renal arteries was sensitive to Gβγ blockade the EPAC-dependent relaxations were not. Finally, myristolated-SRKALNILGYPDYD, which liberates Gβγ without GTP exchange on the Gα (Goubaeva et al., 2003), relaxed precontracted renal arteries in a linopirdine-sensitive manner. Overall, there is considerable evidence that Gβγ association with Kv7.4 is essential for the channel to respond to membrane voltage changes and is a necessary requirement for the channel to respond to receptor-mediated signals. Disabling Kv7.4-Gβγ interactions reduces channel currents and in arteries leads to marked vasospasm and poor response to many receptor-mediated vasodilators. These data presented a new paradigm to regulate arterial relaxation.
Relationship with PIP2
The activity of Kir3.1/3.4 proteins that comprise GIRK channels are regulated by phosphatidyl inositol bisphosphate (PIP2) and intracellular sodium levels as well as Gβγ (Petit-Jacques et al., 1999; Wang et al., 2014; Li et al., 2019). Ultrastructural studies have identified that full activation of Kir3.1/3.4 by Gβγ is contingent upon PIP2 stabilising an internal gate distinct from a Gβγ binding site (Whorton and Mackinnon, 2011; 2013). Kv7 channels activity is also reliant upon PIP2 interaction (Li et al., 2005; Brown et al., 2007; Hernandez et al., 2008). Kv7.4 has the lowest sensitivity of all Kv7 channels to PIP2 with an EC50 value in excised patches of about 120 uM (Li et al., 2005; Brown et al., 2007; Hernandez et al., 2008; Povstyan et al., 2017). Povstyan et al. (2017) revealed that the stimulatory effect of PIP2 on Kv7.4 in excised patches was prevented by prior application of structurally different Gβγ blockers (gallein, M199K, M201 and Grk2i). Strikingly, the stimulatory effect of Gβγ subunits was abrogated by depletion of PIP2 levels through activation of phospholipase C linked receptors in the presence of the P-I-3 kinase inhibitor, wortmannin (Povstyan et al., 2017). Affirmation of a cooperative regulation of Kv7.4 by both signal entities was provided by the observation that a sub-efficacious concentration of Gβγ (1 ng/mL), enhanced the action of low PIP2 concentrations to maximal levels (Povstyan et al., 2017). These data suggest that the sensitivity of Kv7.4 to PIP2 may be dependent on local Gβγ levels and vice versa. Thus, channel regulation is dictated by a synergism of Gβγ and PIP2 like the situation for GIRK channels (Dascal and Kahanovitch, 2015; Li et al., 2019).
Reflections
The observation that Gβγ stimulated Kv7.4 channels was seminal, and the physiological implications are manifold. However, many questions now exist. Importantly, structural information about the site of Gβγ interaction with Kv7.4 is lacking. Moreover, the molecular mechanisms that link Gβγ with enhanced channel activity and the precise role of Gβγ in the modulation produced by protein kinase A and EPACs remain to be defined. In addition, the role of KCNE subunits in Gβγ-mediated regulation has not been assessed. Future research should address these short falls.
Research into Gβγ regulation of Kv channels is in its infancy and mechanistic insight is scarce. The effect of Gβγ on Kv7.4 channels is extremely powerful and appears to be linked to underlying modulatory processes especially PIP2-dependent increases in open probability. Information on the other Kv7 subtypes is lacking. As Kv7.2/7.3 heteromers constitute the M-channel that stabilise neuronal membrane potential Gβγ regulation would have a considerable physiological impact. Interestingly, there are various neurodevelopmental disorders that are linked to mutations in the Gβ genes (GNB1 and 2; e.g., Petrovski et al., 2016). Similarly, Kv7.1 in association has a key role in regulating action potential duration in paced cardiomyocytes and a reliance upon Gβγ association would have much impact on cardiac function. The effect of Gβγ on other Kv channels is very limited with data only on Kv1.1 and auxiliary subunit mediated channel inactivation (see Jing et al., 1999; Michaelevski et al., 2002). In contrast to the Kir3. x family that underlie GIRK channels, the Kv family is considerably larger and more complex in terms of modulation by auxiliary proteins. Defining how Gβγ modulate Kv channel activity will be a busy area for years to come.
Author contributions
JS: Data curation, Formal Analysis, Investigation, Methodology, Validation, Writing–review and editing. IG: Conceptualization, Funding acquisition, Project administration, Resources, Supervision, Visualization, Writing–original draft, Writing–review and editing.
Funding
The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This work was supported by British Heart Foundation grant (PG/15/97/31862) to IG.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
References
Abbott G. W. (2020). KCNQs: ligand- and voltage-gated potassium channels. Front. Physiol. 11, 583. doi:10.3389/fphys.2020.00583
Abbott G. W. (2022). Kv Channel ancillary subunits: where do we go from here? Physiol. (Bethesda) 37 (5), 0. doi:10.1152/physiol.00005.2022
Baldwin S. N., Forrester E. A., McEwan L., Greenwood I. A. (2022). Sexual dimorphism in prostacyclin-mimetic responses within rat mesenteric arteries: a novel role for KV 7.1 in shaping IP receptor-mediated relaxation. Br. J. Pharmacol. 179 (7), 1338–1352. doi:10.1111/bph.15722
Barrese V., Stott J. B., Greenwood I. A. (2018). KCNQ-encoded potassium channels as therapeutic targets. Annu. Rev. Pharmacol. Toxicol. 58, 625–648. doi:10.1146/annurev-pharmtox-010617-052912
Barhanin J., Lesage F., Guillemare E., Fink M., Lazdunski M., Romey G., et al. (1996). K(V)LQT1 and lsK (minK) proteins associate to form the I(Ks) cardiac potassium current. Nature 384 (6604), 78–80. doi:10.1038/384078a0
Brown D. A., Hughes S. A., Marsh S. J., Tinker A. (2007). Regulation of M(Kv7.2/7.3) channels in neurons by PIP(2) and products of PIP(2) hydrolysis: significance for receptor-mediated inhibition. J. Physiol. 582 (Pt 3), 917–925. doi:10.1113/jphysiol.2007.132498
Brueggemann L. I., Cribbs L. L., Byron K. L. (2020). Structural determinants of Kv7.5 potassium channels that confer changes in phosphatidylinositol 4,5-bisphosphate (PIP2) affinity and signaling sensitivities in smooth muscle cells. Mol. Pharmacol. 97 (3), 145–158. doi:10.1124/mol.119.117192
Brueggemann L. I., Mackie A. R., Cribbs L. L., Freda J., Tripathi A., Majetschak M., et al. (2014). Differential protein kinase C-dependent modulation of Kv7.4 and Kv7.5 subunits of vascular Kv7 channels. J. Biol. Chem. 289 (4), 2099–2111. doi:10.1074/jbc.M113.527820
Carr G., Barrese V., Stott J. B., Povstyan O. V., Jepps T. A., Figueiredo H. B., et al. (2016). MicroRNA-153 targeting of KCNQ4 contributes to vascular dysfunction in hypertension. Cardiovasc Res. 112 (2), 581–589. doi:10.1093/cvr/cvw177
Chadha P. S., Jepps T. A., Carr G., Stott J. B., Zhu H. L., Cole W. C., et al. (2014). Contribution of kv7.4/kv7.5 heteromers to intrinsic and calcitonin gene-related peptide-induced cerebral reactivity. Arterioscler. Thromb. Vasc. Biol. 34 (4), 887–893. doi:10.1161/ATVBAHA.114.303405
Chadha P. S., Zunke F., Zhu H. L., Davis A. J., Jepps T. A., Olesen S. P., et al. (2012). Reduced KCNQ4-encoded voltage-dependent potassium channel activity underlies impaired β-adrenoceptor-mediated relaxation of renal arteries in hypertension. Hypertension 59 (4), 877–884. doi:10.1161/HYPERTENSIONAHA.111.187427
Choveau F. S., De la Rosa V., Bierbower S. M., Hernandez C. C., Shapiro M. S. (2018). Phosphatidylinositol 4,5-bisphosphate (PIP2) regulates KCNQ3 K+ channels by interacting with four cytoplasmic channel domains. J. Biol. Chem. 293 (50), 19411–19428. doi:10.1074/jbc.RA118.005401
Huang C., Slesinger P. A., Casey P. J., Nung Jan Y., Jan L. Y. (1995). Evidence that direct binding of G beta gamma to the GIRK1 G protein-gated inwardly rectifying K+ channel is important for channel activation. Neuron 15 (5), 1133–1143. doi:10.1016/0896-6273(95)90101-9
Coetzee W. A., Amarillo Y., Chiu J., Chow A., Lau D., McCormack T., et al. (1999). Molecular diversity of K+ channels. Ann. N. Y. Acad. Sci. 868, 233–285. doi:10.1111/j.1749-6632.1999.tb11293.x
Dascal N., Kahanovitch U. (2015). The roles of Gβγ and Gα in gating and regulation of GIRK channels. Int. Rev. Neurobiol. 123, 27–85. doi:10.1016/bs.irn.2015.06.001
Dupré D. J., Robitaille M., Rebois R. V., Hébert T. E. (2009). The role of Gbetagamma subunits in the organization, assembly, and function of GPCR signaling complexes. Annu. Rev. Pharmacol. Toxicol. 49, 31–56. doi:10.1146/annurev-pharmtox-061008-103038
Gamper N., Li Y., Shapiro M. S. (2005). Structural requirements for differential sensitivity of KCNQ K+ channels to modulation by Ca2+/calmodulin. Mol. Biol. Cell 16 (8), 3538–3551. doi:10.1091/mbc.e04-09-0849
Goubaeva F., Ghosh M., Malik S., Yang J., Hinkle P. M., Griendling K. K., et al. (2003). Stimulation of cellular signaling and G protein subunit dissociation by G protein betagamma subunit-binding peptides. J. Biol. Chem. 278 (22), 19634–19641. doi:10.1074/jbc.M300052200
Greenwood I. A., Stott J. B. (2020). The Gβ1 and Gβ3 subunits differentially regulate rat vascular Kv7 channels. Front. Physiol. 10, 1573. doi:10.3389/fphys.2019.01573
Greenwood I. A., Ohya S. (2009). New tricks for old dogs: KCNQ expression and role in smooth muscle. Br J Pharmacol. 156 (8), 1196–1203. doi:10.1111/j.1476-5381.2009.00131.x
Haick J. M., Byron K. L. (2016). Novel treatment strategies for smooth muscle disorders: targeting Kv7 potassium channels. Pharmacol. Ther. 165, 14–25. doi:10.1016/j.pharmthera.2016.05.002
Haitin Y., Attali B. (2008). The C-terminus of Kv7 channels: a multifunctional module. J. Physiol. 586 (7), 1803–1810. doi:10.1113/jphysiol.2007.149187
He C., Yan X., Zhang H., Mirshahi T., Jin T., Huang A., et al. (2002). Identification of critical residues controlling G protein-gated inwardly rectifying K(+) channel activity through interactions with the beta gamma subunits of G proteins. J. Biol. Chem. 277 (8), 6088–6096. doi:10.1074/jbc.M104851200
He C., Zhang H., Mirshahi T., Logothetis D. E. (1999). Identification of a potassium channel site that interacts with G protein betagamma subunits to mediate agonist-induced signaling. J. Biol. Chem. 274 (18), 12517–12524. doi:10.1074/jbc.274.18.12517
Herlitze S., Garcia D. E., Mackie K., Hille B., Scheuer T., Catterall W. A. (1996). Modulation of Ca2+ channels by G-protein beta gamma subunits. Nature 380 (6571), 258–262. doi:10.1038/380258a0
Hernandez C. C., Zaika O., Tolstykh G. P., Shapiro M. S. (2008). Regulation of neural KCNQ channels: signalling pathways, structural motifs and functional implications. J. Physiol. 586 (7), 1811–1821. doi:10.1113/jphysiol.2007.148304
Huang Y., Ma D., Yang Z., Zhao Y., Guo J. (2023). Voltage-gated potassium channels KCNQs: structures, mechanisms, and modulations. Biochem. Biophys. Res. Commun. 689, 149218. doi:10.1016/j.bbrc.2023.149218
Ikeda S. R. (1996). Voltage-dependent modulation of N-type calcium channels by G-protein beta gamma subunits. Nature 380 (6571), 255–258. doi:10.1038/380255a0
Ivanina T., Rishal I., Varon D., Mullner C., Frohnwieser-Steinecke B., Schreibmayer W., et al. (2003). Mapping the Gbetagamma-binding sites in GIRK1 and GIRK2 subunits of the G protein-activated K+ channel. J. Biol. Chem. 278 (31), 29174–29183. doi:10.1074/jbc.M304518200
Jentsch T. J. (2000). Neuronal KCNQ potassium channels: physiology and role in disease. Nat. Rev. Neurosci. 1 (1), 21–30. doi:10.1038/35036198
Jepps T. A., Carr G., Lundegaard P. R., Olesen S. P., Greenwood I. A. (2015). Fundamental role for the KCNE4 ancillary subunit in Kv7.4 regulation of arterial tone. J. Physiol. 593 (24), 5325–5340. doi:10.1113/JP271286
Jepps T. A., Chadha P. S., Davis A. J., Harhun M. I., Cockerill G. W., Olesen S. P., et al. (2011). Downregulation of Kv7.4 channel activity in primary and secondary hypertension. Circulation 124 (5), 602–611. doi:10.1161/CIRCULATIONAHA.111.032136
Jepps T. A., Olesen S. P., Greenwood I. A., Dalsgaard T. (2016). Molecular and functional characterization of Kv 7 channels in penile arteries and corpus cavernosum of healthy and metabolic syndrome rats. Br. J. Pharmacol. 173 (9), 1478–1490. doi:10.1111/bph.13444
Jing J., Chikvashvili D., Singer-Lahat D., Thornhill W. B., Reuveny E., Lotan I. (1999). Fast inactivation of a brain K+ channel composed of Kv1.1 and Kvbeta1.1 subunits modulated by G protein beta gamma subunits. EMBO J. 18 (5), 1245–1256. doi:10.1093/emboj/18.5.1245
Kahanovitch U., Tsemakhovich V., Berlin S., Rubinstein M., Styr B., Castel R., et al. (2014). Recruitment of Gβγ controls the basal activity of G-protein coupled inwardly rectifying potassium (GIRK) channels: crucial role of distal C terminus of GIRK1. J. Physiol. 592 (24), 5373–5390. doi:10.1113/jphysiol.2014.283218
Khan S. M., Sleno R., Gora S., Zylbergold P., Laverdure J. P., Labbe J. C., et al. (2013). The expanding roles of Gβγ subunits in G protein-coupled receptor signaling and drug action. Pharmacol. Rev. 65, 545–577. doi:10.1124/pr.111.005603
Khan S. M., Sung J. Y., Hebert T. E. (2016). Gβγ subunits – different spaces, different faces. Pharmacol. Res. 111, 434–441. doi:10.1016/j.phrs.2016.06.026
Khanamiri S., Soltysinska E., Jepps T. A., Bentzen B. H., Chadha P. S., Schmitt N., et al. (2013). Contribution of Kv7 channels to basal coronary flow and active response to ischemia. Hypertension 62 (6), 1090–1097. doi:10.1161/HYPERTENSIONAHA.113.01244
Lin Y., Smrcka A. V. (2011). Understanding molecular recognition by G protein βγ subunits on the path to pharmacological targeting. Mol Pharmacol. 80 (4), 551–557. doi:10.1124/mol.111.073072
Li D., Jin T., Gazgalis D., Cui M., Logothetis D. E. (2019). On the mechanism of GIRK2 channel gating by phosphatidylinositol bisphosphate, sodium, and the Gβγ dimer. J. Biol. Chem. 294 (49), 18934–18948. doi:10.1074/jbc.RA119.010047
Li Y., Gamper N., Hilgemann D. W., Shapiro M. S. (2005). Regulation of Kv7 (KCNQ) K+ channel open probability by phosphatidylinositol 4,5-bisphosphate. J. Neurosci. 25 (43), 9825–9835. doi:10.1523/JNEUROSCI.2597-05.2005
Logothetis D. E., Kurachi Y., Galper J., Neer E. J., Clapham D. E. (1987). The beta gamma subunits of GTP-binding proteins activate the muscarinic K+ channel in heart. Nature 325 (6102), 321–326. doi:10.1038/325321a0
McCallum L. A., Pierce S. L., England S. K., Greenwood I. A., Tribe R. M. (2011). The contribution of Kv7 channels to pregnant mouse and human myometrial contractility. J. Cell Mol. Med. 15 (3), 577–586. doi:10.1111/j.1582-4934.2010.01021.x
Meens M. J., Mattheij N. J., van Loenen P. B., Spijkers L. J., Lemkens P., Nelissen J., et al. (2012). G-protein βγ subunits in vasorelaxing and anti-endothelinergic effects of calcitonin gene-related peptide. Br. J. Pharmacol. 166 (1), 297–308. doi:10.1111/j.1476-5381.2011.01774.x
Michaelevski I., Chikvashvili D., Tsuk S., Fili O., Lohse M. J., Singer-Lahat D., et al. (2002). Modulation of a brain voltage-gated K+ channel by syntaxin 1A requires the physical interaction of Gbetagamma with the channel. J. Biol. Chem. 277 (38), 34909–34917. doi:10.1074/jbc.M203943200
Mondéjar-Parreño G., Moral-Sanz J., Barreira B., De la Cruz A., Gonzalez T., Callejo M., et al. (2019). Activation of Kv 7 channels as a novel mechanism for NO/cGMP-induced pulmonary vasodilation. Br. J. Pharmacol. 176 (13), 2131–2145. doi:10.1111/bph.14662
Morales-Cano D., Moreno L., Barreira B., Pandolfi R., Chamorro V., Jimenez R., et al. (2015). Kv7 channels critically determine coronary artery reactivity: left-right differences and down-regulation by hyperglycaemia. Cardiovasc Res. 106 (1), 98–108. doi:10.1093/cvr/cvv020
Nakajo K., Kubo Y. (2007). KCNE1 and KCNE3 stabilize and/or slow voltage sensing S4 segment of KCNQ1 channel. J. Gen. Physiol. 130 (3), 269–281. doi:10.1085/jgp.200709805
Nappi P., Miceli F., Soldovieri M. V., Ambrosino P., Barrese V., Taglialatela M. (2020). Epileptic channelopathies caused by neuronal Kv7 (KCNQ) channel dysfunction. Pflugers Arch. 472 (7), 881–898. doi:10.1007/s00424-020-02404-2
Petit-Jacques J., Sui J. L., Logothetis D. E. (1999). Synergistic activation of G protein-gated inwardly rectifying potassium channels by the betagamma subunits of G proteins and Na(+) and Mg(2+) ions. J. Gen. Physiol. 114 (5), 673–684. doi:10.1085/jgp.114.5.673
Petrovski S., Küry S., Myers C. T., Anyane-Yeboa K., Cogné B., Bialer M., et al. (2016). Germline de novo mutations in GNB1 cause severe neurodevelopmental disability, hypotonia, and seizures. Am. J. Hum. Genet. 98 (5), 1001–1010. doi:10.1016/j.ajhg.2016.03.011
Povstyan O. V., Barrese V., Stott J. B., Greenwood I. A. (2017). Synergistic interplay of Gβγ and phosphatidylinositol 4,5-bisphosphate dictates Kv7.4 channel activity. Pflugers Arch. 469 (2), 213–223. doi:10.1007/s00424-016-1916-4
Proft J., Weiss N. (2015). G protein regulation of neuronal calcium channels: back to the future. Mol. Pharmacol. 87 (6), 890–906. doi:10.1124/mol.114.096008
Ranjan R., Logette E., Marani M., Herzog M., Tâche V., Scantamburlo E., et al. (2019). A kinetic map of the homomeric voltage-gated potassium channel (kv) family. Front. Cell Neurosci. 13, 358. doi:10.3389/fncel.2019.00358
Schmidt C. J., Thomas T. C., Levine M. A., Neer E. J. (1992). Specificity of G protein beta and gamma subunit interactions. J. Biol. Chem. 267, 13807–13810. doi:10.1016/s0021-9258(19)49638-5
Schwake M., Athanasiadu D., Beimgraben C., Blanz J., Beck C., Jentsch T. J., et al. (2006). Structural determinants of M-type KCNQ (Kv7) K+ channel assembly. J. Neurosci. 26 (14), 3757–3766. doi:10.1523/JNEUROSCI.5017-05.2006
Schwake M., Jentsch T. J., Friedrich T. (2003). A carboxy-terminal domain determines the subunit specificity of KCNQ K+ channel assembly. EMBO Rep. 4 (1), 76–81. doi:10.1038/sj.embor.embor715
Soderberg O., Leuchowius K. J., Gullberg M., Jarvius M., Weibrecht I., Larsson L. G., et al. (2008). Characterizing proteins and their interactions in cells and tissues using the in situ proximity ligation assay. Methods 45 (3), 227–232. doi:10.1016/j.ymeth.2008.06.014
Soldovieri M. V., Miceli F., Taglialatela M. (2011). Driving with no brakes: molecular pathophysiology of Kv7 potassium channels. Physiol. (Bethesda) 26 (5), 365–376. doi:10.1152/physiol.00009.2011
Stott J. B., Barrese V., Greenwood I. A. (2016). Kv7 channel activation underpins EPAC-dependent relaxations of rat arteries. Arterioscler. Thromb. Vasc. Biol. 36 (12), 2404–2411. doi:10.1161/ATVBAHA.116.308517
Stott J. B., Barrese V., Jepps T. A., Leighton E. V., Greenwood I. A. (2015a). Contribution of Kv7 channels to natriuretic peptide mediated vasodilation in normal and hypertensive rats. Hypertension 65 (3), 676–682. doi:10.1161/HYPERTENSIONAHA.114.04373
Stott J. B., Barrese V., Suresh M., Masoodi S., Greenwood I. A. (2018). Investigating the role of G protein βγ in kv7-dependent relaxations of the rat vasculature. Arterioscler. Thromb. Vasc. Biol. 38 (9), 2091–2102. doi:10.1161/ATVBAHA.118.311360
Stott J. B., Povstyan O. V., Carr G., Barrese V., Greenwood I. A. (2015b). G-protein βγ subunits are positive regulators of Kv7.4 and native vascular Kv7 channel activity. Proc. Natl. Acad. Sci. U. S. A. 112 (20), 6497–6502. doi:10.1073/pnas.1418605112
Sun J., MacKinnon R. (2020). Structural basis of human KCNQ1 modulation and gating. Cell 180 (2), 340–347. doi:10.1016/j.cell.2019.12.003
Svalø J., Sheykhzade M., Nordling J., Matras C., Bouchelouche P. (2015). Functional and molecular evidence for Kv7 channel subtypes in human detrusor from patients with and without bladder outflow obstruction. PLoS One 10 (2), e0117350. doi:10.1371/journal.pone.0117350
Tabak G., Keren-Raifman T., Kahanovitch U., Dascal N. (2019). Mutual action by Gγ and Gβ for optimal activation of GIRK channels in a channel subunit-specific manner. Sci. Rep. 9 (1), 508. doi:10.1038/s41598-018-36833-y
Tobelaim W. S., Dvir M., Lebel G., Cui M., Buki T., Peretz A., et al. (2017). Competition of calcified calmodulin N lobe and PIP2 to an LQT mutation site in Kv7.1 channel. Proc. Natl. Acad. Sci. U. S. A. 114 (5), E869–E878. doi:10.1073/pnas.1612622114
Touhara K. K., MacKinnon R. (2018). Molecular basis of signaling specificity between GIRK channels and GPCRs. Elife 7, e42908. doi:10.7554/eLife.42908
Vigil F. A., Carver C. M., Shapiro M. S. (2020). Pharmacological manipulation of K v 7 channels as a new therapeutic tool for multiple brain disorders. Front. Physiol. 11, 688. doi:10.3389/fphys.2020.00688
Wang W., Whorton M. R., MacKinnon R. (2014). Quantitative analysis of mammalian GIRK2 channel regulation by G proteins, the signaling lipid PIP2 and Na+ in a reconstituted system. Elife 3, e03671. doi:10.7554/eLife.03671
Wang Y., Eldstrom J., Fedida D. (2020). Gating and regulation of KCNQ1 and KCNQ1 + KCNE1 channel complexes. Front. Physiol. 11, 504. doi:10.3389/fphys.2020.00504
Whorton M. R., MacKinnon R. (2011). Crystal structure of the mammalian GIRK2 K+ channel and gating regulation by G proteins, PIP2, and sodium. Cell 147 (1), 199–208. doi:10.1016/j.cell.2011.07.046
Whorton M. R., MacKinnon R. (2013). X-ray structure of the mammalian GIRK2-βγ G-protein complex. Nature 498 (7453), 190–197. doi:10.1038/nature12241
Keywords: Kv7, KCNQ, Gβγ, M channel, vasorelaxation
Citation: Stott JB and Greenwood IA (2024) G protein βγ regulation of KCNQ-encoded voltage-dependent K channels. Front. Physiol. 15:1382904. doi: 10.3389/fphys.2024.1382904
Received: 06 February 2024; Accepted: 25 March 2024;
Published: 09 April 2024.
Edited by:
Lubica Lacinova, Slovak Academy of Sciences (SAS), SlovakiaReviewed by:
Erick Omar Hernandez-Ochoa, University of Maryland, United StatesPaula G. Socuéllamos, Autonomous University of Madrid, Spain
Kevin Currie, Cooper Medical School of Rowan University, United States
Copyright © 2024 Stott and Greenwood. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Iain A. Greenwood, Z3Jlbndvb2RAc2d1bC5hYy51aw==